<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147419" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Glycol Ether Toxicology</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Parmjyot J.</given-names>
          </name>
          <aff>Jefferson Northeast</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Penn</surname>
            <given-names>Spencer</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Vincent R.</given-names>
          </name>
          <aff>Northwell Health/Zucker School of Medicine at Hofstra School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Parmjyot Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Spencer Penn declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vincent Lee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147419.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Glycol ethers are a class of organic solvents commonly found in industrial and household products. These chemicals are solvents for various applications, including resins, lacquers, varnishes, gums, perfumes, dyes, and inks. Glycol ethers are components in paint, pastes, household cleaning products, liquid soaps, cosmetic products, and hydraulic fluids. These substances may be categorized into 2 groups depending on the manufacturing process: ethylene oxide-derived (E-series) or propylene oxide-derived (P-series).</p>
        <p>Glycol ether toxicity can occur via multiple routes and injure various organs. Clinicians must understand these compounds' clinical toxicology, given their widespread use and risk for significant toxicity.</p>
        <p>This activity for healthcare professionals is designed to improve learners' proficiency in evaluating and managing glycol ether toxicology. Participants gain valuable insights into the condition's epidemiology, pathophysiology, toxicokinetics, clinical presentation, and management of glycol ethers, equipping them to collaborate effectively within an interprofessional team caring for patients with glycol ether poisoning.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between acute and chronic&#x000a0;glycol ether toxicity clinical presentations.</p></list-item><list-item><p>Create a clinically guided diagnostic plan for a patient with possible glycol ether poisoning.</p></list-item><list-item><p>Develop an individualized management strategy for a patient diagnosed with glycol ether poisoning.</p></list-item><list-item><p>Implement best interprofessional communication and coordination&#x000a0;practices&#x000a0;to formulate short- and long-term care plans for patients with glycol ether toxicity.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147419&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147419">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-147419.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Glycol ethers have been a versatile and essential solvent group widely utilized in industrial and commercial settings&#x000a0;since their initial development in the 1930s. Glycol ethers possess a unique&#x000a0;combination&#x000a0;of physical properties, including high solvency,&#x000a0;low evaporation rates, and miscibility&#x000a0;with both water and organic substances.<xref ref-type="bibr" rid="article-147419.r1">[1]</xref><xref ref-type="bibr" rid="article-147419.r2">[2]</xref>&#x000a0;These characteristics make glycol ethers&#x000a0;essential in manufacturing various products, including paint and ink formulations, cleaners, cosmetics, pharmaceuticals, circuit boards, and hydraulic brake fluids.<xref ref-type="bibr" rid="article-147419.r3">[3]</xref></p>
        <p>Traditionally,&#x000a0;glycol ethers are&#x000a0;classified&#x000a0;based on their precursor molecules. Ethylene oxide-derived glycol ethers belong to the E-series, while molecules derived from&#x000a0;propylene oxide are classified as&#x000a0;P-series glycol ethers. The utility of E-series glycol ethers (EGEs), such as methyl-, ethyl-, butyl-, and hexyl-GEs, has diminished&#x000a0;due to&#x000a0;increasing reports of their toxic effects.<xref ref-type="bibr" rid="article-147419.r4">[4]</xref><xref ref-type="bibr" rid="article-147419.r5">[5]</xref><xref ref-type="bibr" rid="article-147419.r6">[6]</xref><xref ref-type="bibr" rid="article-147419.r7">[7]</xref>&#x000a0;EGEs are metabolized into&#x000a0;their respective alkoxyacetic acids, producing&#x000a0;neurologic, hematologic, renal, hepatic, endocrine, teratogenic, and reproductive effects. Consequently, the relatively safer P-series glycol ethers (PGEs) have mostly replaced EGEs.<xref ref-type="bibr" rid="article-147419.r8">[8]</xref><xref ref-type="bibr" rid="article-147419.r9">[9]</xref><xref ref-type="bibr" rid="article-147419.r10">[10]</xref><xref ref-type="bibr" rid="article-147419.r11">[11]</xref><xref ref-type="bibr" rid="article-147419.r12">[12]</xref><xref ref-type="bibr" rid="article-147419.r13">[13]</xref></p>
        <p>PGEs include&#x000a0;methyl-, ethyl-, n-propyl-, butyl, and phenyl propylene glycol ethers (see <bold>Image</bold>. Propylene Glycol n-Butyl Ether Structure). These chemicals are&#x000a0;often preferred due to their comparatively lower toxicity profiles. PGEs are commonly found in paints, coatings, semiconductor processes, resins, cleaners, sunscreen, and pharmaceuticals.<xref ref-type="bibr" rid="article-147419.r14">[14]</xref>&#x000a0;Propylene glycol has many applications due to its solvent properties.&#x000a0;A&#x000a0;key example is its use in lorazepam and diazepam infusions.<xref ref-type="bibr" rid="article-147419.r15">[15]</xref></p>
        <p>Glycol ether exposure may&#x000a0;occur in both household and occupational settings through inhalation, dermal contact, or ingestion. Occupations most vulnerable to glycol ether exposure include&#x000a0;cleaners, printing machine operators, semiconductor manufacturing workers, chemical industry workers, automobile mechanics, cosmeticians, secretaries, and printers.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-147419.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Glycol ethers are&#x000a0;rapidly&#x000a0;absorbed via dermal, inhalational, and gastrointestinal routes. Ingestion is the least likely mode of exposure but has the greatest potential to cause toxicity. Intentional ingestion of glycol ethers has been documented.<xref ref-type="bibr" rid="article-147419.r16">[16]</xref><xref ref-type="bibr" rid="article-147419.r17">[17]</xref>&#x000a0;EGEs possess a primary alcohol and are&#x000a0;metabolized by alcohol dehydrogenase, producing toxic alkoxyacetic acids. Organic acid accumulation is generally responsible for causing EGEs' renal, neurologic, and reproductive side effects. In contrast, PGEs&#x000a0;lack a primary alcohol group and thus cannot produce toxic metabolites.<xref ref-type="bibr" rid="article-147419.r18">[18]</xref><xref ref-type="bibr" rid="article-147419.r19">[19]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-147419.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Limited human epidemiological data regarding the association between reproductive outcomes and glycol ethers is available. Epidemiological studies&#x000a0;focus mostly on EGEs, particularly 2-methoxyethanol, 2-ethoxyethanol, and 2-butoxyethanol (see <bold>Image</bold>. Structure of 2-Butoxyethanol). These studies include&#x000a0;case reports, animal research, and limited prospective cohorts.<xref ref-type="bibr" rid="article-147419.r20">[20]</xref><xref ref-type="bibr" rid="article-147419.r21">[21]</xref><xref ref-type="bibr" rid="article-147419.r22">[22]</xref> Furthermore, these&#x000a0;investigations&#x000a0;are often&#x000a0;confounded&#x000a0;by exposures to other occupational chemicals.</p>
        <p>Animal models first displayed EGEs' toxic reproductive effects in the 1970s, prompting investigations in the United States a decade later. France partially regulated the compound in 1992, but the first complete ban on using&#x000a0;glycol ethers in drugs and cosmetics occurred in 1999.</p>
        <p>Occupational exposures&#x000a0;comprise most cases since&#x000a0;glycol ethers have a ubiquitous industrial role. Semiconductor factory workers are the most vulnerable to&#x000a0;reproductive toxicity. A 1996&#x000a0;American retrospective cohort study reported an increased relative risk of spontaneous abortions among female workers in semiconductor manufacturing facilities.<xref ref-type="bibr" rid="article-147419.r23">[23]</xref>&#x000a0;Similarly, a 1997 European case-controlled study reported that women exposed to&#x000a0;glycol ethers had increased odds of having children with congenital disabilities, especially neural tube defects and cleft lips.<xref ref-type="bibr" rid="article-147419.r24">[24]</xref></p>
        <p>Epidemiological studies likewise show that shipyard workers exposed to&#x000a0;glycol ethers have a high prevalence of oligospermia and azoospermia.<xref ref-type="bibr" rid="article-147419.r25">[25]</xref><xref ref-type="bibr" rid="article-147419.r26">[26]</xref>&#x000a0;Notably, a&#x000a0;2020 French study demonstrated the widespread detection of glycol ether metabolites in 6-year-old children undergoing neurodevelopmental evaluation<xref ref-type="bibr" rid="article-147419.r27">[27]</xref></p>
        <p>The United States Poison Control Centers reported 6,411 ethylene glycol exposures in 2018, with&#x000a0;most cases being unintentional (78%). Among these exposures, 469 occurred in children aged 5 years or younger.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1080/24734306.2022.2045123">[88]</ext-link></p>
      </sec>
      <sec id="article-147419.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>EGEs are metabolized by the liver enzyme alcohol dehydrogenase into toxic alkoxyacetic acids. These organic acids are primarily responsible for EGEs' renal, neurologic, and reproductive side effects.<xref ref-type="bibr" rid="article-147419.r11">[11]</xref><xref ref-type="bibr" rid="article-147419.r12">[12]</xref>. The most frequently studied EGE compounds include 2-methoxyethanol, 2-ethoxyethanol, 2-butoxyethanol, 2-propoxyethanol, 2-isopropoxyethanol, and 2-phenoxyethanol.&#x000a0;</p>
        <p>
<bold>Neurological Injury</bold>
</p>
        <p>Acute encephalopathy characterized by confusion, agitation, and depressed mental status has been described in serious EGE poisonings.<xref ref-type="bibr" rid="article-147419.r28">[28]</xref><xref ref-type="bibr" rid="article-147419.r29">[29]</xref><xref ref-type="bibr" rid="article-147419.r30">[30]</xref>. The onset of personality changes, memory loss, headaches, dizziness, ataxia, tremors, and lethargy characterizes chronic toxicity by occupational exposure to high EGE levels.<xref ref-type="bibr" rid="article-147419.r31">[31]</xref>&#x000a0;Animal models demonstrate EGEs' capacity to cross the blood-brain barrier. <italic toggle="yes">In vivo</italic> studies show that administering EGE mixtures to rats' frontal cortex and hippocampus leads to reduced antioxidant capacity, heightened lipid peroxidation, and elevated caspase-3 activity, indicating oxidative stress as the mechanism of EGE toxicity.</p>
        <p>
<bold>Renal Damage</bold>
</p>
        <p>Acute kidney injury and proteinuria have been reported following acute EGE ingestion.<xref ref-type="bibr" rid="article-147419.r32">[32]</xref>&#x000a0;Alkoxyacetic acid-induced renal tubular degeneration and necrosis have been found in both animal models and autopsies after fatal EGE poisoning.<xref ref-type="bibr" rid="article-147419.r33">[33]</xref><xref ref-type="bibr" rid="article-147419.r34">[34]</xref></p>
        <p>
<bold>Hepatic Effects</bold>
</p>
        <p>Glycol ethers are predominantly metabolized in the liver. Hepatic injury arises from various mechanisms. The first is through mitochondrial disruption by EGE metabolism-derived reactive oxygen species, impairing cellular metabolism. The second is primarily mediated by hemolysis and iron deposition in the liver. Iron deposition activates Kupffer cells through the Fenton/Haber-Weiss reactions, releasing more reactive oxygen species and inducing TNF-&#x003b1; production.<xref ref-type="bibr" rid="article-147419.r35">[35]</xref>&#x000a0;</p>
        <p>Studies also show that diethylene glycol monomethyl ether (DiEGME) and ethylene glycol monomethyl (EGME) increase microsomal protein concentrations and induce hepatic enzymes. Specifically, DiEGME increases cytochrome P-450 but not cytochrome b5 or NADPH-cytochrome c reductase.<xref ref-type="bibr" rid="article-147419.r36">[36]</xref>&#x000a0;EGME, on the other hand, has the opposite effect. The reason for the specificity of certain EGEs toward particular hepatic enzymes remains unclear, as does the correlation between the hepatotoxic effects of glycol ethers and the concentration of glycolic acid. These biochemical changes may manifest as hepatic steatosis and aminotransferase derangements due to toxic metabolite accumulation in the liver. Some studies conclude that patients with underlying liver disease would have less functional alcohol dehydrogenase to produce toxic metabolites, creating a less severe clinical presentation.<xref ref-type="bibr" rid="article-147419.r37">[37]</xref></p>
        <p>
<bold>Reproductive Toxicity</bold>
</p>
        <p>Certain EGEs&#x000a0;are associated with reproductive toxicity and neurodevelopmental disorders.<xref ref-type="bibr" rid="article-147419.r38">[38]</xref><xref ref-type="bibr" rid="article-147419.r39">[39]</xref>&#x000a0;Numerous animal studies demonstrate testicular weight changes, edema, and tubular atrophy. Routine EGE exposure&#x000a0;has been shown to reduce sperm maturation steps.</p>
        <p>Daily 2-methoxyethanol administration to pregnant mice delays neurogenesis and morphogenesis, specifically neural tube closure and limb and digit formation.<xref ref-type="bibr" rid="article-147419.r40">[40]</xref>&#x000a0;Researchers have determined that glycol ether metabolism to acetic acid is the primary driver of teratogenicity. The compound 2-methoxyacetic acid gets incorporated into the metabolic pathways during embryogenesis. Coenzyme A converts 2-methoxyacetic acid to a thioester, similar to acetic acid's transformation into the Krebs cycle intermediate acetyl CoA.</p>
        <p>Researchers found that carbon-labeled CO2 was excreted in embryonic cultures exposed to carbon-labeled 2-methoxyacetic acid. However, competitive inhibitors such as acetate and serine could inhibit 2-methoxyacetic acid incorporation into the metabolic pathways. Serine was likewise found to counteract the decline in sperm production and micromorphological changes caused by toxicity related to 2-methoxyethanol.</p>
        <p>
<bold>Hematologic Manifestations</bold>
</p>
        <p>Butoxyethanol has been specifically identified as potentially toxic to the bone marrow. Studies show that animal exposure leads to hemolysis, hemoglobinuria, leukopenia, and decreased bone marrow cellularity. Further investigation reveals that &#x003b2;-aminolevulinic acid production is a critical factor in hemolysis induction.<xref ref-type="bibr" rid="article-147419.r41">[41]</xref><xref ref-type="bibr" rid="article-147419.r42">[42]</xref></p>
        <p><italic toggle="yes">In vitro</italic>&#x000a0;animal studies likewise demonstrate EGEs' time- and concentration-dependent hemolytic effect, preceded by a decrease in adenosine triphosphate levels and erythrocyte swelling. The underlying mechanisms behind this phenomenon remain poorly understood, but the erythrocyte membrane appears to be the damage site. Another possibility is that reactive oxygen species generated by the parent glycol ethers cause lipid peroxidation.</p>
        <p>
<bold>Lymphatic Damage</bold>
</p>
        <p>Early animal studies investigated male rat immune reactions after a 4-day EGME dermal exposure at doses of 150 to 1200 mg/kg/day. Thymus and spleen weights were found to decline across all amounts at higher doses. Additionally, lymphoproliferative responses were enhanced at 1200 mg/kg/day. However, 4 days of oral EGME administration impaired antibody response at 300 and 600 mg/kg/day. This immunosuppressive response was blocked with the administration of fomepizole, suggesting that 2-methoxyacetic acid is primarily responsible for mediating the process.<xref ref-type="bibr" rid="article-147419.r43">[43]</xref>&#x000a0;A follow-up study showed that different rodent species exhibit sensitivity differences toward EGE.<xref ref-type="bibr" rid="article-147419.r44">[44]</xref>&#x000a0;Research on the lymphogenic response to glycol ethers is limited and requires further investigation to elucidate its effects fully.</p>
        <p>
<bold>Dermatologic Injury</bold>
</p>
        <p>Glycol ethers are easily absorbed through the skin. Molecular weight is a significant determinant of these compounds' absorption rates. Smaller glycol ethers more easily penetrate the skin than larger molecules, with a lag time of 1.5 to 2 hours observed in human experiments.<xref ref-type="bibr" rid="article-147419.r45">[45]</xref>&#x000a0;</p>
        <p>Other compounds can impact glycol ethers' dermal absorption. A study showed that an aqueous mixture of butoxyethanol was absorbed 6 times more efficiently than a pure glycol ether solvent, with the apparent permeability coefficient increasing as the glycol ether concentration in water decreased.<xref ref-type="bibr" rid="article-147419.r46">[46]</xref>&#x000a0;This absorption mechanism is thought to arise from glycol ethers' ability to induce stratum corneum lipid bilayer changes. Glycol ethers undergo cellular metabolism by cytosolic aldehyde dehydrogenase and alcohol dehydrogenase after absorption. These enzymes' concentrations vary in different body sites. Additional research is required to understand the dermatological toxicity of glycol ethers.</p>
      </sec>
      <sec id="article-147419.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Glycol ethers enter the body by ingestion, inhalation, or dermal exposure.<xref ref-type="bibr" rid="article-147419.r47">[47]</xref><xref ref-type="bibr" rid="article-147419.r48">[48]</xref><xref ref-type="bibr" rid="article-147419.r49">[49]</xref>&#x000a0;Ingestion is the most toxic route, while inhalation is the least harmful. Glycol ethers are swiftly absorbed following ingestion and have a large distribution volume. Glycol ethers are metabolized via alcohol dehydrogenase, producing toxic metabolites.&#x000a0;</p>
        <p>Similarly, glycol ethers are eliminated through urinary excretion, contrasting with methanol, which undergoes hepatic elimination.<xref ref-type="bibr" rid="article-147419.r50">[50]</xref><xref ref-type="bibr" rid="article-147419.r51">[51]</xref>&#x000a0;Human studies indicate that EGME inhalation results in the excretion of unchanged alkoxyacetic acid in urine shortly after exposure. Animal research suggests that elimination occurs via the organic acid transport mechanism. The half-life of glycol ethers typically ranges from 1 to 24 hours, and variations occur between glycol ethers and their respective organic acids. For instance, ethylene glycol monobutyl ether has a half-life of approximately 1 hour, while its resulting organic acid, butoxyacetic acid, has a half-life of about 4 hours.<xref ref-type="bibr" rid="article-147419.r52">[52]</xref><xref ref-type="bibr" rid="article-147419.r53">[53]</xref></p>
      </sec>
      <sec id="article-147419.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History&#x000a0;</bold>
</p>
        <p>Patients may present to the emergency room reporting accidental or nonaccidental exposure to a glycol ether-containing product. For example, some may disclose having ingested brake fluid or antifreeze. Symptoms vary in severity. Many exposures do not lead to significant illness, leaving most patients asymptomatic. Fatal cases are rare and typically result from significant ingestion. However, chronically exposed individuals may consult in the outpatient setting for insidiously developing symptoms or an incidental abnormal laboratory finding.</p>
        <p>Acute glycol ether toxicity may present with gastrointestinal and acute kidney injury symptoms, such as nausea, emesis, decreased urine output, shortness of breath, and abdominal pain. Seizures, headaches, altered sensorium, agitation, weakness, chest pain, and upper gastrointestinal bleeding may also be reported. A history of ingesting large amounts of glycol ether is often elicited.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1186/s41935-021-00244-4">[89]</ext-link>&#x000a0;Acute hemolysis may also arise, manifesting as weakness, pallor, or syncope.</p>
        <p>Patients initially with oliguria due to kidney damage and dehydration may later develop osmotic diuresis. This paradoxical manifestation may arise&#x000a0;due to the&#x000a0;accumulation of osmotically active substances in the renal tubules.&#x000a0;Consequently, water reabsorption is inhibited and urine output increases despite ongoing renal injury.</p>
        <p>A detailed past medical and social history is essential in elucidating glycol ether toxicity. Patients with acute exposures may have recent emotional trauma or belong to a home with safety deficiencies. Inquiring about using commonplace household items such as surface cleaner, all-purpose cleaner, window cleaner, paint, laundry detergents, and cosmetics is also essential. Remember that glycol ether poisoning may resemble toxicity from alcohols such as methanol and exacerbated medical conditions such as diabetic ketoacidosis. Obtaining a psychiatric history is also important because reports of intentional ingestion exist with suicide attempts. Patients with severe presentations may not provide history, highlighting the importance of collateral information from emergency medical services.</p>
        <p>Occupational history is crucial&#x000a0;in patients with chronic toxicity. Workers in various industries, such as electronics, printing, paint and coating, textiles, adhesives, cleaning, and personal care products may have been inadvertently exposed.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_12819971">[53]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_11981652">[54]</ext-link>&#x000a0;Additionally, workers in industries that use glycol ether solvents or as product components, such as laboratory technicians, janitorials, and construction workers, may also be at risk.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_8588559">[55]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_11100951">[56]</ext-link>&#x000a0;</p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>The physical examination of a patient who has ingested glycol ethers can vary based on several factors, including the amount consumed, the time since ingestion, and individual patient characteristics. As a result, examination findings can be classified into 3 categories based on disease onset and duration: acute, subacute, or chronic. Some&#x000a0;features of these conditions&#x000a0;may overlap.</p>
        <p>
<bold>Findings&#x000a0;consistent with&#x000a0;acute toxicity&#x000a0;</bold>
</p>
        <p>Patients who ingested a large amount may be visibly agitated, confused, or unconscious, with symptoms developing within hours.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_9004463">[57]</ext-link>&#x000a0;Metabolic acidosis from acute kidney injury may manifest as tachypnea or hyperventilation.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_21804082">[58]</ext-link>&#x000a0;Heart blocks, refractory shock, and various metabolic derangements have been reported in some individuals.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_31218140">[59]</ext-link>&#x000a0;Patients may have signs of severe dehydration from vomiting, such as dry oral mucosa, sunken eyeballs, tachycardia, and poor capillary refill.</p>
        <p>
<bold>Findings&#x000a0;consistent with subacute toxicity</bold>
</p>
        <p>Neurological signs predominate after 5 to 10 days, including progressive lethargy, bilateral facial paralysis, dysphonia, and nonreactive pupils. Peripheral neuropathies impact specific nerve groups, including the 3rd, 5th, 6th, and 9th through 12th cranial nerves. Focal central nervous system involvement has been described bilaterally in the left partial lobe and occipital and cerebellar regions.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_15902788">[61]</ext-link>&#x000a0;Localized skin erythema, dryness, and, in some cases, allergic reactions are possible, depending on the duration and frequency of exposure.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/adminreviewdiffs/?id=164651#ref_34510410">[62]</ext-link></p>
        <p>
<bold><bold>Findings&#x000a0;consistent with&#x000a0;c</bold>hronic toxicity</bold>
</p>
        <p>Chronic toxicity, occurring at least 2 weeks&#x000a0;after initial exposure, may present with central and peripheral nervous system impairment and can progress to coma. Impaired respiratory function is possible, although the spectrum of long-term neurological injury is variable. Repetitive chronic exposure can also cause weakness, drowsiness, anisocoria (irregular pupils), and hypersomnolence. The resulting pancytopenia can present as a myriad of symptoms related to anemia and immunodeficiency. However, little research exists regarding the long-term sequelae of bone marrow suppression from glycol ether toxicity. Patients may also report a longstanding history of infertility, decreased testicular size, spontaneous abortions, and congenital malformations in the offspring.</p>
      </sec>
      <sec id="article-147419.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Laboratory Tests</bold>
</p>
        <p>Basic laboratory tests, such as a complete metabolic panel and blood count, are recommended to assess for various electrolyte derangements and anemia. Hypocalcemia may be noted in the case of ethylene glycol toxicity. Elevated blood urea nitrogen (BUN), potassium, and creatinine are consistent with renal failure.</p>
        <p>Respiratory distress signs like tachypnea warrant an arterial blood gas (ABG) analysis. This test provides information about acid-base balance, oxygenation status, and respiratory function. In cases of glycol ether toxicity, ABG can help assess the severity of metabolic acidosis and respiratory compensation. ABG results can guide treatment decisions, such as the need for respiratory support acid-base imbalance correction.</p>
        <p>Metabolic acidosis in the setting of lactic acidosis is often accompanied by a high anion gap, calculated according to the following equation:</p>
        <p>Anion Gap = ([Sodium concentration] + [Potassium concentration]) - ([Chloride concentration] + [Bicarbonate concentration])</p>
        <p>In glycol ether toxicity cases, an elevated anion gap may be observed due to the accumulation of toxic metabolites, such as glycolic acid or oxalic acid, which are not routinely measured in standard laboratory tests but contribute to the blood's overall anion load.</p>
        <p>The osmolality gap is the difference between the measured and calculated serum osmolality. This parameter provides an estimate of unmeasured osmotically active substances in the blood. The calculated serum osmolality is based on the concentrations of sodium, glucose, and BUN. An elevated osmolality gap may indicate the presence of substances not typically measured in standard laboratory tests, such as glycol ethers or their metabolites. Osmotic diuresis is likely accompanied by a high osmolality gap and a low anion gap.<xref ref-type="bibr" rid="article-147419.r54">[54]</xref></p>
        <p>However, recognizing the limitations of utilizing the osmolality gap is important when evaluating glycol ether poisoning. Clinicians should be vigilant of overtly elevated osmolality gaps (ie, &#x0003e;30 mOsl/L) in the presence of altered mental status or other signs suggesting toxic ingestion.</p>
        <p>Patients who present early may have a normal anion gap and elevated osmolality gap, as the parent compound has not transformed into its respective organic acid. On the other hand, patients who present late have had time to metabolize the glycol ether, which may produce a high anion gap. Metabolic conversion of the parent compound lowers its quantity, as seen in late-presenting patients. A normal osmolarity gap may be observed in such individuals.&#x000a0;</p>
        <p>Lactate levels are measured to assess tissue perfusion and determine lactate's contribution to metabolic acidosis. Elevated lactate levels may indicate tissue hypoperfusion and severe toxicity.</p>
        <p>Coingestions of other toxic substances may occur with glycol ether exposure. Screening for common coingestants such as acetaminophen, ethanol, methanol, and salicylates helps identify additional toxicities that may require specific interventions or treatments.</p>
        <p>Urinalysis is performed to assess renal function and detect any abnormalities such as hematuria, proteinuria, or crystalluria that may indicate kidney injury or dysfunction secondary to glycol ether toxicity. Urinalysis findings can also help monitor the progression of renal impairment and guide treatment decisions.</p>
        <p>Time-consuming metabolite testing of organic acids is of little utility, especially in the acute setting. Many hospitals do not routinely test for metabolites.<xref ref-type="bibr" rid="article-147419.r55">[55]</xref><xref ref-type="bibr" rid="article-147419.r56">[56]</xref></p>
        <p>
<bold>Electrocardiography</bold>
</p>
        <p>Electrocardiography is also essential for detecting conduction abnormalities, which can be a byproduct of various electrolyte derangements and acidosis. ECG findings should be interpreted in conjunction with the patient's clinical presentation, laboratory results, and overall clinical context to guide diagnosis and management.</p>
        <p>
<bold>Imaging&#x000a0;</bold>
</p>
        <p>A computed tomography (CT) scan of the head may help rule out other causes of altered mental status. However, this modality may be of low value in assessing neurological damage due to the systemic nature of the primary etiology. Meanwhile, the utility of obtaining magnetic resonance imaging (MRI) is unclear, as evidence of neurologic injury may not be evident in this study.</p>
        <p>A case series by Yahi et al reported that initial head CT scans in patients with glycol ether toxicity were without abnormality. Two patients initially had unrevealing MRIs, but a third demonstrated edema and herniation. These initial MRI findings may hold a poor prognosis. Other reports showed regular MRIs in patients with fatal outcomes. Yahi et al also mention brain atrophy in 2 of their surviving cases but with typical MRIs, questioning the true etiology of these findings. Brain imaging to evaluate glycol ether toxicity requires further investigation.</p>
        <p>Chest imaging may also be considered to evaluate for pneumonitis from exposure to glycol ether vapor or aspiration in the setting of altered mental status. An abdominal ultrasound may help identify changes in size, texture, and even necrosis in the kidney and liver.</p>
        <p>
<bold>Electroencephalogram and Electromyography</bold>
</p>
        <p>Nerve conduction studies may also be beneficial in evaluating neuropathy. A case study reported that most patients with glycol ether exposure and elevated CSF protein, without pleocytosis, developed a neurological injury. An electroencephalogram may be helpful in patients with repeated seizures, although limited reports of this initial presentation exist.<xref ref-type="bibr" rid="article-147419.r57">[57]</xref></p>
      </sec>
      <sec id="article-147419.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The initial treatment for glycol ether toxicity involves addressing the patient's airway, breathing, circulation, disability, and exposure. After the primary survey, additional therapies depend on the presentation's severity, often determined by which glycol ether was ingested, the route, and the time elapsed since ingestion. Glycol ether exerts toxicity primarily through its alkoxyacetic acid metabolite produced by alcohol dehydrogenase. Treatment aims to inhibit the production of the toxic metabolite and subsequent removal of the parent compound.<xref ref-type="bibr" rid="article-147419.r58">[58]</xref>&#x000a0;Fomepizole, an alcohol dehydrogenase inhibitor, is administered, and the parent compound is urgently eliminated via extracorporeal enhanced elimination by hemodialysis.<xref ref-type="bibr" rid="article-147419.r59">[59]</xref>&#x000a0;</p>
        <p>Fomepizole monotherapy may be considered if the toxic compound has a short elimination half-life (ie, less than the half-life of fomepizole) in a patient with normal renal function. More importantly, these treatment strategies would benefit most during the early toxicity stages. As such, early suspicion of glycol ether toxicity is paramount. Note that fomepizole carries a half-life of about 12 hours and is therefore started at 15 mg/kg every 12 hours.<xref ref-type="bibr" rid="article-147419.r60">[60]</xref><xref ref-type="bibr" rid="article-147419.r61">[61]</xref>&#x000a0;Additional adjustments may be required per hemodialysis and other patient-specific factors, such as a history of chronic kidney disease. The dialysability of a toxin primarily depends on its free plasma concentration, size, weight, and volume of distribution.<xref ref-type="bibr" rid="article-147419.r62">[62]</xref>&#x000a0;Small, unbound toxins with a low distribution volume are readily removed by dialysis.<xref ref-type="bibr" rid="article-147419.r63">[63]</xref><xref ref-type="bibr" rid="article-147419.r64">[64]</xref>&#x000a0;Therefore, patients with toxicity to glycol ether exposure would benefit from hemodialysis.&#x000a0;</p>
        <p>Propylene glycol, a secondary alcohol, is structurally similar to glycol ethers but is generally less toxic. Both alcohols are metabolized by alcohol dehydrogenase and produce toxic metabolites. However, alcohol dehydrogenase does not readily metabolize propylene glycol because this glycol's hydroxyl group is bound to&#x000a0;a secondary carbon. Nonetheless, propylene glycol toxicity management follows the same principle for glycol ether toxicity: inhibition of alcohol dehydrogenase with fomepizole and toxic alcohol removal with hemodialysis.<xref ref-type="bibr" rid="article-147419.r65">[65]</xref><xref ref-type="bibr" rid="article-147419.r66">[66]</xref>&#x000a0;</p>
        <p>Electrolyte management may also be beneficial, particularly in hyperkalemia and severe metabolic acidosis. Intubation and mechanical ventilation may become necessary if the patient has severe respiratory distress or no longer protecting their airway due to a depressed sensorium. Blood transfusions may also be needed if hemolysis results in severe anemia.&#x000a0;</p>
        <p>The use of gastric decontamination has not been closely studied. Some authors suggest gastric lavage or nasogastric decontamination, but the benefits of these interventions within the first 1 to 2 hours of ingestion have not been studied. Obtaining an accurate history is another limitation of using gastric lavage. Moreover, as neurotoxicity is a common finding, gastric decontamination may increase the risk of pulmonary aspiration.</p>
        <p>Activated charcoal is also not recommended, as the substance has a poor affinity for alcohol.<xref ref-type="bibr" rid="article-147419.r67">[67]</xref>&#x000a0;No precise dedicated study suggests using N-acetylcysteine (NAC) to treat glycol ether-induced hepatic injury. However, given that the hepatic injury is mediated by oxidative stress, NAC may provide some utility in theory.<xref ref-type="bibr" rid="article-147419.r68">[68]</xref>&#x000a0;Animal studies suggest that NAC prevents genetic damage in testicular germ cells induced by 2-methylacetic acid, an organic acid that also mediates the disease process in glycol ether toxicity.<xref ref-type="bibr" rid="article-147419.r68">[68]</xref></p>
      </sec>
      <sec id="article-147419.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of glycol ether toxicity includes ingesting similar toxic alcohols such as methanol and isopropyl alcohol. Toxic ingestions of these compounds produce metabolic acidosis&#x000a0;similar to&#x000a0;glycol ether toxicity.&#x000a0;However, the lethal dose and toxicokinetics differ. Drug overdoses may also present&#x000a0;with neurological and metabolic derangements.</p>
      </sec>
      <sec id="article-147419.s11" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Managing glycol ether toxicity depends on factors such as ingested amount, time since exposure, and coingestions. Additionally, underlying comorbid conditions, such as chronic renal failure, should be considered when evaluating treatment options.&#x000a0;</p>
      </sec>
      <sec id="article-147419.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>A favorable prognosis&#x000a0;is associated with early hospitalization. Respiratory compensation offsetting metabolic acidosis&#x000a0;also correlates with a better prognosis.&#x000a0;Key findings&#x000a0;associated with a poor prognosis include severe neurological damage (eg, coma), respiratory failure, profound metabolic arrangements requiring dialysis, acidosis with a pH of less than 7, and delayed hospital evaluation.<xref ref-type="bibr" rid="article-147419.r69">[69]</xref><xref ref-type="bibr" rid="article-147419.r70">[70]</xref>&#x000a0;Ethylene glycol toxicity fatalities have been reported to follow acute renal failure requiring hemodialysis.<xref ref-type="bibr" rid="article-147419.r71">[71]</xref></p>
      </sec>
      <sec id="article-147419.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Glycol ether toxicity complications primarily affect the neurologic and renal systems. Seizures and evidence of cranial palsies and structural brain changes have been documented.<xref ref-type="bibr" rid="article-147419.r72">[72]</xref>&#x000a0;Clinical case reports and epidemic studies, such as the Panama mass poisoning incident, indicate that patients may experience axonal sensorimotor neuropathy, peripheral neuropathy, cranial nerve neuropathies, and demyelination. Some complications may occur in the acute to subacute stages, while others may develop months after the initial presentation in patients who survive the acute poisoning. However, limited long-term longitudinal studies are available.&#x000a0;</p>
        <p>Severe hypocalcemia and acidosis may result in cardiac dysrhythmias and acute renal failure, which may require dialysis. Electrolyte imbalances, pancreatitis, and acidemia are expected acute complications likely related to renal failure, encephalopathy, and peripheral neuropathies. Additionally, a few isolated case reports suggest that significant acute glycol ether ingestion can cause pulmonary edema.<xref ref-type="bibr" rid="article-147419.r73">[73]</xref>&#x000a0;However, further research is needed to determine whether the glycol ether or the overall critical presentation causes the respiratory insult.</p>
        <p>In patients who survive glycol ether toxicity, the long-term complications can vary widely. For example, mild kidney injury may resolve, but those who require hemodialysis generally remain dialysis-dependent.<xref ref-type="bibr" rid="article-147419.r74">[74]</xref><xref ref-type="bibr" rid="article-147419.r75">[75]</xref><xref ref-type="bibr" rid="article-147419.r76">[76]</xref>&#x000a0;Patients may also experience neurological complications, such as neurocognitive changes or quadriplegia, due to oxidative stress and demyelinating injury. A higher risk of developing neurological sequelae has been observed in renal failure patients. The variability of these complications is likely related to the patient's initial presentation.</p>
        <p>Oxidative stress caused by glycol ether metabolites can damage the liver, although the long-term hepatic effects have not been studied. Evidence is insufficient to support that glycol toxicity increases malignancy risk. Studies on glycol ether exposure and the risk of developing acute myeloid leukemia&#x000a0;do not show statistically significant results. Furthermore, no concrete evidence proves that glycol ether toxicity causes genotoxic changes.<xref ref-type="bibr" rid="article-147419.r77">[77]</xref>&#x000a0;Some research indicates that in-utero exposure to glycol ether may reduce telomere length and increase chromatid exchange, but further research is needed to investigate genotoxicity.<xref ref-type="bibr" rid="article-147419.r78">[78]</xref></p>
      </sec>
      <sec id="article-147419.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consulting with the nearest poison control center and, if available, the institutional medical toxicologist is highly recommended. Specialists&#x000a0;such as nephrologists, neurologists, and intensivists&#x000a0;may be needed to manage complications such as renal and respiratory failure, seizures, and hyperkalemia.</p>
      </sec>
      <sec id="article-147419.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Household supplies such as cleaning, paint, and automotive liquids should be kept safe and secure, especially from young children,&#x000a0;to prevent accidental pediatric ingestions.<xref ref-type="bibr" rid="article-147419.r58">[58]</xref><xref ref-type="bibr" rid="article-147419.r66">[66]</xref>&#x000a0;The reduction of occupational exposure to glycol ethers requires the implementation of both respiratory and dermal protection strategies. Engineering controls, such as using exhaust ventilation in small closed spaces, are key examples. Personal&#x000a0;protective equipment, such as gloves, respiratory masks, facial shields, and protective clothing, may be necessary to prevent dermal exposure.&#x000a0;The choice of personal protective equipment is determined by the specific glycol ether used and the potential exposure.</p>
      </sec>
      <sec id="article-147419.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The following are the most important aspects to remember about glycol ether poisoning evaluation and management:</p>
        <list list-type="bullet">
          <list-item>
            <p>Upon exposure, glycol ethers are metabolized to their respective&#x000a0;alkoxyacetic acids, which orchestrate systemic toxicity.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Alcohol dehydrogenase is the primary means of metabolism, and excretion is primarily by the kidneys.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Although the half-life of glycol ethers is relatively short, evaluating for coingestions that can prolong clearance through competitive enzyme inhibition is paramount.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute toxicity is generally mild to moderate and can result in skin irritation, metabolic derangements,&#x000a0;central nervous system depression, hemolytic anemia, and spermatogenesis defects. Fatal cases are rare and are likely the result of significant ingestion.</p>
          </list-item>
          <list-item>
            <p>Chronic toxicity can result in hematological side effects (eg, anemia, bone marrow suppression), hepatic histologic changes, and reproductive and developmental damage.</p>
          </list-item>
          <list-item>
            <p>Managing glycol ether toxicity is similar to toxic alcohol ingestions and begins with assessing the airway, breathing, and circulation, followed by supportive measures.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The&#x000a0;2 primary avenues for treatment are fomepizole and hemodialysis for managing acute toxicity, which may provide the most benefit if given early.</p>
          </list-item>
        </list>
        <p>Patients with glycol ether toxicity may require long-term follow-up for monitoring of renal function, neurological sequelae, and potential development of chronic complications. Close collaboration with toxicology specialists and nephrologists can optimize patient care and outcomes.</p>
      </sec>
      <sec id="article-147419.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Early diagnosis of glycol ether ingestion to prevent further toxic metabolite production is critical. Assessing and managing toxic ingestions requires an interprofessional approach that includes clinicians, specialists, nursing staff, and pharmacists. An institutional medical toxicologist and a local poison control center must be consulted, if available. Recommendations by a medical toxicologist and nephrologist may be necessary for managing metabolic acidosis and renal failure through hemodialysis. An intensivist may be involved in the care of patients requiring intubation, mechanical ventilation, and hemodynamic support.</p>
        <p>Interprofessional care coordination between clinicians and specialists, nursing staff, and pharmacists is necessary. The nursing staff administers medication and monitors patient responses. Pharmacists can perform medication reconciliation, verify dosing, and assist in patient drug therapy counseling. Management of long-term side effects such as permanent disability or reproductive defects requires consultations with primary care physicians, neurologists, urologists, and gynecologists. The interprofessional care paradigm is crucial to optimal patient outcomes.</p>
      </sec>
      <sec id="article-147419.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147419&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147419">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/poisons/glycol-ether-toxicology/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147419">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147419/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147419">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-147419.s19">
        <fig id="article-147419.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Structure of 2-Butoxyethanol. This image shows the chemical structure of the ethylene oxide-derived glycol ether 2-butoxyethanol. The hydroxyl group is attached to a primary carbon. Contributed from Wikimedia Commons; https://en.m.wikipedia.org/wiki/File:2-butoxyethanol_structure.svg</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="2-butoxyethanol_structure.svg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-147419.s20">
        <fig id="article-147419.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Propylene Glycol n-Butyl Ether Structure. This image shows the chemical structure of the propylene oxide-derived glycol ether propylene glycol n-butyl ether. The hydroxyl group is attached to a secondary carbon. https://www.carlroth.com/com/en/a-to-z/propylene-glycol-butyl-ether/p/209k.1</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Propylene__glycol__butyl__ether" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-147419.s21">
        <title>References</title>
        <ref id="article-147419.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelsey</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Propylene oxide derived glycol ethers: A review of the alkyl glycol ethers potential to cause endocrine disruption.</article-title>
            <source>Regul Toxicol Pharmacol</source>
            <year>2023</year>
            <month>Jun</month>
            <day>30</day>
            <fpage>105442</fpage>
            <pub-id pub-id-type="pmid">37394030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelsey</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Ethylene oxide derived glycol ethers: A review of the alkyl glycol ethers potential to cause endocrine disruption.</article-title>
            <source>Regul Toxicol Pharmacol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>129</volume>
            <fpage>105113</fpage>
            <pub-id pub-id-type="pmid">34974128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Browning</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Clinical toxicology of ethylene glycol monoalkyl ethers.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>1994</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>325</fpage>
            <page-range>325-35</page-range>
            <pub-id pub-id-type="pmid">8043314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirtana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seetharaman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Comprehending the Role of Endocrine Disruptors in Inducing Epigenetic Toxicity.</article-title>
            <source>Endocr Metab Immune Disord Drug Targets</source>
            <year>2022</year>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1059</fpage>
            <page-range>1059-1072</page-range>
            <pub-id pub-id-type="pmid">35410624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beattie</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Brabec</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Methoxyacetic acid and ethoxyacetic acid inhibit mitochondrial function in vitro.</article-title>
            <source>J Biochem Toxicol</source>
            <year>1986</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>61</fpage>
            <page-range>61-70</page-range>
            <pub-id pub-id-type="pmid">3271880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Effects of ethylene glycol monomethyl ether on various parameters of testicular function in the F344 rat.</article-title>
            <source>Environ Health Perspect</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>57</volume>
            <fpage>219</fpage>
            <page-range>219-24</page-range>
            <pub-id pub-id-type="pmid">6541998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koyano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oobayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Testicular atrophy of mice induced by ethylene glycol mono alkyl ethers (author's transl)].</article-title>
            <source>Sangyo Igaku</source>
            <year>1979</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-35</page-range>
            <pub-id pub-id-type="pmid">470211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sulsh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Gangolli</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Acute toxicity and recovery in the hemopoietic system of rats after treatment with ethylene glycol monomethyl and monobutyl ethers.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>1985</year>
            <month>Feb</month>
            <volume>77</volume>
            <issue>2</issue>
            <fpage>187</fpage>
            <page-range>187-200</page-range>
            <pub-id pub-id-type="pmid">3975897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalf</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Post</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Solvent toxicology: recent advances in the toxicology of benzene, the glycol ethers, and carbon tetrachloride.</article-title>
            <source>Annu Rev Pharmacol Toxicol</source>
            <year>1987</year>
            <volume>27</volume>
            <fpage>399</fpage>
            <page-range>399-427</page-range>
            <pub-id pub-id-type="pmid">3555320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rambourg-Schepens</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Buffet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bertault</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jaussaud</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Journe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lamiable</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Severe ethylene glycol butyl ether poisoning. Kinetics and metabolic pattern.</article-title>
            <source>Hum Toxicol</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>187</fpage>
            <page-range>187-9</page-range>
            <pub-id pub-id-type="pmid">3378807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welsch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The mechanism of ethylene glycol ether reproductive and developmental toxicity and evidence for adverse effects in humans.</article-title>
            <source>Toxicol Lett</source>
            <year>2005</year>
            <month>Mar</month>
            <day>28</day>
            <volume>156</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-28</page-range>
            <pub-id pub-id-type="pmid">15705484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johanson</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Toxicity review of ethylene glycol monomethyl ether and its acetate ester.</article-title>
            <source>Crit Rev Toxicol</source>
            <year>2000</year>
            <month>May</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-45</page-range>
            <pub-id pub-id-type="pmid">10852499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wess</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Reproductive toxicity of ethylene glycol monomethyl ether, ethylene glycol monoethyl ether and their acetates.</article-title>
            <source>Scand J Work Environ Health</source>
            <year>1992</year>
            <volume>18 Suppl 2</volume>
            <fpage>43</fpage>
            <page-range>43-5</page-range>
            <pub-id pub-id-type="pmid">1514082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spencer</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>New toxicity data for the propylene glycol ethers - a commitment to public health and safety.</article-title>
            <source>Toxicol Lett</source>
            <year>2005</year>
            <month>Mar</month>
            <day>28</day>
            <volume>156</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-8</page-range>
            <pub-id pub-id-type="pmid">15705495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yusufzai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Graeber</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.</article-title>
            <source>Nat Clin Pract Nephrol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>9</issue>
            <fpage>515</fpage>
            <page-range>515-20</page-range>
            <pub-id pub-id-type="pmid">17717564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schep</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Slaughter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Temple</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Beasley</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Diethylene glycol poisoning.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>525</fpage>
            <page-range>525-35</page-range>
            <pub-id pub-id-type="pmid">19586352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cicolella</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Glycol ethers: a ubiquitous family of toxic chemicals: a plea for REACH regulation.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>1076</volume>
            <fpage>784</fpage>
            <page-range>784-9</page-range>
            <pub-id pub-id-type="pmid">17119255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lockley</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Howes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous metabolism of glycol ethers.</article-title>
            <source>Arch Toxicol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-8</page-range>
            <pub-id pub-id-type="pmid">15551062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vecer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kub&#x000e1;tov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Charv&#x000e1;t</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Soucek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kvapil</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Ethylene glycol poisoning].</article-title>
            <source>Cas Lek Cesk</source>
            <year>2001</year>
            <month>Jun</month>
            <day>21</day>
            <volume>140</volume>
            <issue>12</issue>
            <fpage>381</fpage>
            <page-range>381-2</page-range>
            <pub-id pub-id-type="pmid">11503188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanley</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Ethylene glycol monomethyl ether (EGME) and propylene glycol monomethyl ether (PGME): inhalation fertility and teratogenicity studies in rats, mice and rabbits.</article-title>
            <source>Environ Health Perspect</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>57</volume>
            <fpage>7</fpage>
            <page-range>7-12</page-range>
            <pub-id pub-id-type="pmid">6499821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garlant&#x000e9;zec</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Labat</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rouget</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Monfort</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonvallot</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Roig</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pulkkinen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chevrier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Multigner</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Exposure during pregnancy to glycol ethers and chlorinated solvents and the risk of congenital malformations.</article-title>
            <source>Epidemiology</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>806</fpage>
            <page-range>806-12</page-range>
            <pub-id pub-id-type="pmid">23007043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chevrier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dananch&#x000e9;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bahuau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nelva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Francannet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Robert-Gnansia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cordier</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to organic solvent mixtures during pregnancy and the risk of non-syndromic oral clefts.</article-title>
            <source>Occup Environ Med</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>63</volume>
            <issue>9</issue>
            <fpage>617</fpage>
            <page-range>617-23</page-range>
            <pub-id pub-id-type="pmid">16644895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Correa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rothman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Seacat</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Corn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ethylene glycol ethers and risks of spontaneous abortion and subfertility.</article-title>
            <source>Am J Epidemiol</source>
            <year>1996</year>
            <month>Apr</month>
            <day>01</day>
            <volume>143</volume>
            <issue>7</issue>
            <fpage>707</fpage>
            <page-range>707-17</page-range>
            <pub-id pub-id-type="pmid">8651233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bergeret</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goujard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Aym&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Calzolari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>De Walle</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Knill-Jones</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Candela</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dananch&#x000e9;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Vigan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fevotte</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kiel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mandereau</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Congenital malformation and maternal occupational exposure to glycol ethers. Occupational Exposure and Congenital Malformations Working Group.</article-title>
            <source>Epidemiology</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-63</page-range>
            <pub-id pub-id-type="pmid">9209847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Waxman</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Toxicity of ethylene glycol monomethyl ether: impact on testicular gene expression.</article-title>
            <source>Int J Androl</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-74</page-range>
            <pub-id pub-id-type="pmid">18179559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snow</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to glycol ethers: implications for occupational health nurses.</article-title>
            <source>AAOHN J</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>413</fpage>
            <page-range>413-9</page-range>
            <pub-id pub-id-type="pmid">7945591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garlant&#x000e9;zec</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Warembourg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Le Gl&#x000e9;au</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Montfort</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rouget</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Multigner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cordier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chevrier</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Exposure to glycol ethers among 6-year-old children in France.</article-title>
            <source>Int J Hyg Environ Health</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>227</volume>
            <fpage>113510</fpage>
            <pub-id pub-id-type="pmid">32172156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gijsenbergh</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Jenco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veulemans</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Groeseneken</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Verberckmoes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Delooz</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Acute butylglycol intoxication: a case report.</article-title>
            <source>Hum Toxicol</source>
            <year>1989</year>
            <month>May</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>243</fpage>
            <page-range>243-5</page-range>
            <pub-id pub-id-type="pmid">2744782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dean</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Krenzelok</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Clinical evaluation of pediatric ethylene glycol monobutyl ether poisonings.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1992</year>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-63</page-range>
            <pub-id pub-id-type="pmid">1359160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pomierny</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Starek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krzy&#x0017c;anowska</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Starek-Swiechowicz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Smaga</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pomierny-Chamio&#x00142;o</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Regulska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Budziszewska</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Potential neurotoxic effect of ethylene glycol ethers mixtures.</article-title>
            <source>Pharmacol Rep</source>
            <year>2013</year>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>1415</fpage>
            <page-range>1415-21</page-range>
            <pub-id pub-id-type="pmid">24399739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ZAVON</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Methyl Cellosolve intoxication.</article-title>
            <source>Am Ind Hyg Assoc J</source>
            <year>1963</year>
            <season>Jan-Feb</season>
            <volume>24</volume>
            <fpage>36</fpage>
            <page-range>36-41</page-range>
            <pub-id pub-id-type="pmid">14003323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nitter-Hauge</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Poisoning with ethylene glycol monomethyl ether. Report of two cases.</article-title>
            <source>Acta Med Scand</source>
            <year>1970</year>
            <month>Oct</month>
            <volume>188</volume>
            <issue>4</issue>
            <fpage>277</fpage>
            <page-range>277-80</page-range>
            <pub-id pub-id-type="pmid">5479659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wegman</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous ethylene glycol monomethyl ether poisoning in the work setting.</article-title>
            <source>J Occup Med</source>
            <year>1978</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>675</fpage>
            <page-range>675-6</page-range>
            <pub-id pub-id-type="pmid">722353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laitinen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liesivuori</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Savolainen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Urinary alkoxyacetic acids and renal effects of exposure to ethylene glycol ethers.</article-title>
            <source>Occup Environ Med</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>595</fpage>
            <page-range>595-600</page-range>
            <pub-id pub-id-type="pmid">8882116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Starek-&#x0015a;wiechowicz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Starek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Ethylene glycol and propylene glycol ethers - Reproductive and developmental toxicity].</article-title>
            <source>Med Pr</source>
            <year>2015</year>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>725</fpage>
            <page-range>725-37</page-range>
            <pub-id pub-id-type="pmid">26647990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsuno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kayama</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hirai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arashidani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kodama</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Effect of ethylene glycol monomethyl ether and diethylene glycol monomethyl ether on hepatic metabolizing enzymes.</article-title>
            <source>Toxicology</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-74</page-range>
            <pub-id pub-id-type="pmid">2389243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ming Xing Huang</surname>
              </name>
              <name>
                <surname>Xiao Mou Peng</surname>
              </name>
              <name>
                <surname>Lin Gu</surname>
              </name>
              <name>
                <surname>Gui Hua Chen</surname>
              </name>
            </person-group>
            <article-title>Pre-existing liver cirrhosis reduced the toxic effect of diethylene glycol in a rat model due to the impaired hepatic alcohol dehydrogenase.</article-title>
            <source>Toxicol Ind Health</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>8</issue>
            <fpage>742</fpage>
            <page-range>742-53</page-range>
            <pub-id pub-id-type="pmid">21543465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paustenbach</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the developmental risks resulting from occupational exposure to select glycol ethers within the semiconductor industry.</article-title>
            <source>J Toxicol Environ Health</source>
            <year>1988</year>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-75</page-range>
            <pub-id pub-id-type="pmid">3275786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garlant&#x000e9;zec</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonvallot</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Multigner</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Glycol ethers and congenital malformations.</article-title>
            <source>Epidemiology</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>940</fpage>
            <pub-id pub-id-type="pmid">24077003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terry</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Stedman</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Bolon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Welsch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Effects of 2-methoxyethanol on mouse neurulation.</article-title>
            <source>Teratology</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>219</fpage>
            <page-range>219-29</page-range>
            <pub-id pub-id-type="pmid">9035343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Starek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Szymczak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zapor</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Hematological effects of four ethylene glycol monoalkyl ethers in short-term repeated exposure in rats.</article-title>
            <source>Arch Toxicol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-36</page-range>
            <pub-id pub-id-type="pmid">17874071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Starek-&#x0015a;wiechowicz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miranowicz-Dzier&#x0017c;awska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Szymczak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Budziszewska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Starek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hematological effects of exposure to mixtures of selected ethylene glycol alkyl ethers in rats.</article-title>
            <source>Pharmacol Rep</source>
            <year>2012</year>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>166</fpage>
            <page-range>166-78</page-range>
            <pub-id pub-id-type="pmid">22580533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smialowicz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Riddle</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Luebke</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Copeland</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Laskey</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Immunotoxicity of 2-methoxyethanol following oral administration in Fischer 344 rats.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>494</fpage>
            <page-range>494-506</page-range>
            <pub-id pub-id-type="pmid">1853347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riddle</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Smialowicz</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Repeated high dose oral exposure or continuous subcutaneous infusion of 2-methoxyacetic acid does not suppress humoral immunity in the mouse.</article-title>
            <source>Toxicology</source>
            <year>1996</year>
            <month>May</month>
            <day>03</day>
            <volume>109</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-74</page-range>
            <pub-id pub-id-type="pmid">8619254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Adami</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Larese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maina</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Renzi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous absorption of 5 glycol ethers through human skin in vitro.</article-title>
            <source>Toxicol In Vitro</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>665</fpage>
            <page-range>665-71</page-range>
            <pub-id pub-id-type="pmid">15251185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Traynor</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>The influence of water mixtures on the dermal absorption of glycol ethers.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>2007</year>
            <month>Jan</month>
            <day>15</day>
            <volume>218</volume>
            <issue>2</issue>
            <fpage>128</fpage>
            <page-range>128-34</page-range>
            <pub-id pub-id-type="pmid">17173944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LEAF</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>ZATMAN</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>A study of the conditions under which methanol may exert a toxic hazard in industry.</article-title>
            <source>Br J Ind Med</source>
            <year>1952</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-31</page-range>
            <pub-id pub-id-type="pmid">14895799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frantz</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Beskitt</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Grosse</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tallant</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Ballantyne</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.</article-title>
            <source>Drug Metab Dispos</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>911</fpage>
            <page-range>911-21</page-range>
            <pub-id pub-id-type="pmid">8869828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Driver</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tardiff</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Sedik</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wester</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Maibach</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>In vitro percutaneous absorption of [14C] ethylene glycol.</article-title>
            <source>J Expo Anal Environ Epidemiol</source>
            <year>1993</year>
            <season>Jul-Sep</season>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-84</page-range>
            <pub-id pub-id-type="pmid">8260837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Beysolow</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Kaul</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weisman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Feinfeld</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Clearance of ethylene glycol by kidneys and hemodialysis.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1987</year>
            <volume>25</volume>
            <issue>1-2</issue>
            <fpage>95</fpage>
            <page-range>95-108</page-range>
            <pub-id pub-id-type="pmid">3035205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hovda</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Urdal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Methanol and formate kinetics during treatment with fomepizole.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2005</year>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-7</page-range>
            <pub-id pub-id-type="pmid">16035197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groeseneken</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Veulemans</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Masschelein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Van Vlem</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Experimental human exposure to ethylene glycol monomethyl ether.</article-title>
            <source>Int Arch Occup Environ Health</source>
            <year>1989</year>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>243</fpage>
            <page-range>243-7</page-range>
            <pub-id pub-id-type="pmid">2722247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deisinger</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Guest</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Metabolic studies with diethylene glycol monobutyl ether acetate (DGBA) in the rat.</article-title>
            <source>Xenobiotica</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>981</fpage>
            <page-range>981-9</page-range>
            <pub-id pub-id-type="pmid">2815838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Besenhofer</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Adegboyega</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Filary</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Perala</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>McLaren</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>McMartin</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of metabolism of diethylene glycol prevents target organ toxicity in rats.</article-title>
            <source>Toxicol Sci</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-35</page-range>
            <pub-id pub-id-type="pmid">20530232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blomme</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lheureux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gerlo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maes</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Cobas Mira S endpoint enzymatic assay for plasma formate.</article-title>
            <source>J Anal Toxicol</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-80</page-range>
            <pub-id pub-id-type="pmid">11300510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanton</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>An enzymatic assay for the detection of glycolic acid in serum as a marker of ethylene glycol poisoning.</article-title>
            <source>Ther Drug Monit</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>836</fpage>
            <page-range>836-43</page-range>
            <pub-id pub-id-type="pmid">24263643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imam</surname>
                <given-names>YZB</given-names>
              </name>
              <name>
                <surname>Kamran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Elalamy</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sokrab</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Osman</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Deleu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Neurological manifestation of recreational fatal and near-fatal diethylene glycol poisonings: case series and review of literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>93</volume>
            <issue>10</issue>
            <fpage>e62</fpage>
            <pub-id pub-id-type="pmid">25170933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shear</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heard</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Severe poisoning after accidental pediatric ingestion of glycol ethers.</article-title>
            <source>Pediatrics</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>e1026</fpage>
            <page-range>e1026-9</page-range>
            <pub-id pub-id-type="pmid">23008459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burkhart</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Donovan</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Hemodialysis following butoxyethanol ingestion.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1998</year>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>723</fpage>
            <page-range>723-5</page-range>
            <pub-id pub-id-type="pmid">9865242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drick</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Wiesner</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kielstein</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>[Fomepizole, ethanol or dialysis in the case of life-threatening ethylenglycol intoxication?].</article-title>
            <source>Med Klin Intensivmed Notfmed</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>116</volume>
            <issue>8</issue>
            <fpage>698</fpage>
            <page-range>698-701</page-range>
            <pub-id pub-id-type="pmid">32820350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivilotti</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McMartin</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Brent</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Toxicokinetics of ethylene glycol during fomepizole therapy: implications for management. For the Methylpyrazole for Toxic Alcohols Study Group.</article-title>
            <source>Ann Emerg Med</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-25</page-range>
            <pub-id pub-id-type="pmid">10918102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashby</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Borman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corbett</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farrington</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Flowers</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fotheringham</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrea Fox</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gardiner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin Gerrish</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Greenwood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hothi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Khares</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koufaki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mafrici</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mooney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tattersall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tyerman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wilkie</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Renal Association Clinical Practice Guideline on Haemodialysis.</article-title>
            <source>BMC Nephrol</source>
            <year>2019</year>
            <month>Oct</month>
            <day>17</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>379</fpage>
            <pub-id pub-id-type="pmid">31623578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patzer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Principles of bound solute dialysis.</article-title>
            <source>Ther Apher Dial</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-24</page-range>
            <pub-id pub-id-type="pmid">16684212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sternby</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Significance of distribution volume in dialysis quantification.</article-title>
            <source>Semin Dial</source>
            <year>2001</year>
            <season>Jul-Aug</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>278</fpage>
            <page-range>278-83</page-range>
            <pub-id pub-id-type="pmid">11489203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kraut</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kurtz</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Toxic alcohol ingestions: clinical features, diagnosis, and management.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>208</fpage>
            <page-range>208-25</page-range>
            <pub-id pub-id-type="pmid">18045860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brent</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>401</fpage>
            <page-range>401-6</page-range>
            <pub-id pub-id-type="pmid">20586570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neuvonen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Olkkola</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.</article-title>
            <source>Med Toxicol Adverse Drug Exp</source>
            <year>1988</year>
            <season>Jan-Dec</season>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-58</page-range>
            <pub-id pub-id-type="pmid">3285126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Shaha</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>N-acetylcysteine prevents MAA induced male germ cell apoptosis: role of glutathione and cytochrome c.</article-title>
            <source>FEBS Lett</source>
            <year>2002</year>
            <month>Sep</month>
            <day>11</day>
            <volume>527</volume>
            <issue>1-3</issue>
            <fpage>133</fpage>
            <page-range>133-7</page-range>
            <pub-id pub-id-type="pmid">12220648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassanian-Moghaddam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pajoumand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dadgar</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Shadnia</surname>
                <given-names>Sh</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in methanol poisoning.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>583</fpage>
            <page-range>583-6</page-range>
            <pub-id pub-id-type="pmid">17884962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BENNETT</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>CARY</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>MITCHELL</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>COOPER</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1953</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>431</fpage>
            <page-range>431-63</page-range>
            <pub-id pub-id-type="pmid">13110604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karlson-Stiber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Persson</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Ethylene glycol poisoning: experiences from an epidemic in Sweden.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1992</year>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>565</fpage>
            <page-range>565-74</page-range>
            <pub-id pub-id-type="pmid">1433427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasbani</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sansing</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Perrone</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Asbury</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Encephalopathy and peripheral neuropathy following diethylene glycol ingestion.</article-title>
            <source>Neurology</source>
            <year>2005</year>
            <month>Apr</month>
            <day>12</day>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>1273</fpage>
            <page-range>1273-5</page-range>
            <pub-id pub-id-type="pmid">15824363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mur</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Protois</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bollaert</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Condi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Larcan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Transient non-cardiogenic pulmonary edema following massive ingestion of ethylene glycol butyl ether.</article-title>
            <source>Intensive Care Med</source>
            <year>1992</year>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>250</fpage>
            <page-range>250-1</page-range>
            <pub-id pub-id-type="pmid">1430593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Khare</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dubey</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Harit</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Wadhwa</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Dhariwal</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sokhey</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diethylene glycol poisoning in Gurgaon, India, 1998.</article-title>
            <source>Bull World Health Organ</source>
            <year>2001</year>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-95</page-range>
            <pub-id pub-id-type="pmid">11242827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conklin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sejvar</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kieszak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sabogal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Flanders</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tulloch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Victoria</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McGeehin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Schier</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Long-term renal and neurologic outcomes among survivors of diethylene glycol poisoning.</article-title>
            <source>JAMA Intern Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>174</volume>
            <issue>6</issue>
            <fpage>912</fpage>
            <page-range>912-7</page-range>
            <pub-id pub-id-type="pmid">24819553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Leusen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uges</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>[A patient with acute tubular necrosis as a consequence of drinking diethylene glycol-treated wine].</article-title>
            <source>Ned Tijdschr Geneeskd</source>
            <year>1987</year>
            <month>May</month>
            <day>02</day>
            <volume>131</volume>
            <issue>18</issue>
            <fpage>768</fpage>
            <page-range>768-71</page-range>
            <pub-id pub-id-type="pmid">3587402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGregor</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Genotoxicity of glycol ethers.</article-title>
            <source>Environ Health Perspect</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>57</volume>
            <fpage>97</fpage>
            <page-range>97-103</page-range>
            <pub-id pub-id-type="pmid">6541999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147419.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballantyne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vergnes</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>In vitro and in vivo genetic toxicology studies with diethylene glycol monohexyl ether.</article-title>
            <source>J Appl Toxicol</source>
            <year>2001</year>
            <season>Nov-Dec</season>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>449</fpage>
            <page-range>449-60</page-range>
            <pub-id pub-id-type="pmid">11746191</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
